Literature DB >> 21668291

Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein.

Mohammed Inayathullah1, David B Teplow.   

Abstract

A familial form of Alzheimer disease recently was described in a kindred in Osaka, Japan. This kindred possesses an amyloid β-protein (Aβ) precursor mutation within the Aβ coding region that results in the deletion of Glu22E22). We report here results of studies of [ΔE22]Aβ40 and [ΔE22]Aβ42 that sought to elucidate the conformational dynamics, oligomerization behavior, fibril formation kinetics, fibril morphology, and fibril stability of these mutant peptides. Both [ΔE22]Aβ peptides had extraordinary β-sheet formation propensities. The [ΔE22]Aβ40 mutant formed β-sheet secondary structure elements ≈400-fold faster. Studies of β-sheet stability in the presence of fluorinated alcohol cosolvents or high pH revealed that the ΔE22 mutation substantially increased stability, producing a rank order of [ΔE22]Aβ42 >>Aβ42 > [ΔE22]Aβ40 > Aβ40. The mutation facilitated formation of oligomers by [ΔE22]Aβ42 (dodecamers and octadecamers) that were not observed with Aβ42. Both Aβ40 and Aβ42 peptides formed nebulous globular and small string-like structures immediately upon solvation from lyophilizates, whereas short protofibrillar and fibrillar structures were evident immediately in the ΔE22 samples. Determination of the critical concentration for fibril formation for the [ΔE22]Aβ peptides showed it to be ≈1/2 that of the wild type homologues, demonstrating that the mutations causes a modest increase in fibril stability. The magnitude of this increase, when considered in the context of the extraordinary increase in β-sheet propensity for the ΔE22 peptides, suggests that the primary biophysical effect of the mutation is to accelerate conformational changes in the peptide monomer that facilitate oligomerization and higher-order assembly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21668291      PMCID: PMC3396427          DOI: 10.3109/13506129.2011.580399

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  53 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

2.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

3.  Protofibril assemblies of the arctic, Dutch, and Flemish mutants of the Alzheimer's Abeta1-40 peptide.

Authors:  Nicolas Lux Fawzi; Kevin L Kohlstedt; Yuka Okabe; Teresa Head-Gordon
Journal:  Biophys J       Date:  2007-11-21       Impact factor: 4.033

4.  Amino acid position-specific contributions to amyloid beta-protein oligomerization.

Authors:  Samir K Maji; Rachel R Ogorzalek Loo; Mohammed Inayathullah; Sean M Spring; Sabrina S Vollers; Margaret M Condron; Gal Bitan; Joseph A Loo; David B Teplow
Journal:  J Biol Chem       Date:  2009-06-30       Impact factor: 5.157

5.  Structure of the 21-30 fragment of amyloid beta-protein.

Authors:  Andrij Baumketner; Summer L Bernstein; Thomas Wyttenbach; Noel D Lazo; David B Teplow; Michael T Bowers; Joan-Emma Shea
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

6.  The measurement of cooperative protein self-assembly by turbidity and other techniques.

Authors:  J M Andreu; S N Timasheff
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

7.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 8.  Brain parenchymal and microvascular amyloid in Alzheimer's disease.

Authors:  H V Vinters; Z Z Wang; D L Secor
Journal:  Brain Pathol       Date:  1996-04       Impact factor: 6.508

Review 9.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

10.  Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Authors:  J C Janssen; J A Beck; T A Campbell; A Dickinson; N C Fox; R J Harvey; H Houlden; M N Rossor; J Collinge
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

View more
  18 in total

1.  Familial Alzheimer's disease Osaka mutant (ΔE22) β-barrels suggest an explanation for the different Aβ1-40/42 preferred conformational states observed by experiment.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Bruce L Kagan; Ratnesh Lal; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2013-09-13       Impact factor: 2.991

2.  Stability of Aβ-fibril fragments in the presence of fatty acids.

Authors:  Wenhui Xi; Elliott K Vanderford; Qinxin Liao; Ulrich H E Hansmann
Journal:  Protein Sci       Date:  2019-09-11       Impact factor: 6.725

Review 3.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

4.  The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.

Authors:  Orkid Coskuner; Olivia Wise-Scira; George Perry; Taizo Kitahara
Journal:  ACS Chem Neurosci       Date:  2012-12-18       Impact factor: 4.418

5.  Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.

Authors:  L Kulic; J McAfoose; T Welt; C Tackenberg; C Späni; F Wirth; V Finder; U Konietzko; M Giese; A Eckert; K Noriaki; T Shimizu; K Murakami; K Irie; S Rasool; C Glabe; C Hock; R M Nitsch
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

6.  Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease.

Authors:  Sascha Weggen; Dirk Beher
Journal:  Alzheimers Res Ther       Date:  2012-03-30       Impact factor: 6.982

7.  Atomic-resolution three-dimensional structure of amyloid β fibrils bearing the Osaka mutation.

Authors:  Anne K Schütz; Toni Vagt; Matthias Huber; Oxana Y Ovchinnikova; Riccardo Cadalbert; Joseph Wall; Peter Güntert; Anja Böckmann; Rudi Glockshuber; Beat H Meier
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-13       Impact factor: 15.336

8.  Solvent microenvironments and copper binding alters the conformation and toxicity of a prion fragment.

Authors:  Mohammed Inayathullah; K S Satheeshkumar; Andrey V Malkovskiy; Antoine L Carre; Senthilkumar Sivanesan; Jasper O Hardesty; Jayakumar Rajadas
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

9.  The phosphorylation of Hsp20 enhances its association with amyloid-β to increase protection against neuronal cell death.

Authors:  Ryan T Cameron; Steven D Quinn; Lynn S Cairns; Ruth MacLeod; Ifor D W Samuel; Brian O Smith; J Carlos Penedo; George S Baillie
Journal:  Mol Cell Neurosci       Date:  2014-05-20       Impact factor: 4.314

Review 10.  Amyloid β-protein oligomers and Alzheimer's disease.

Authors:  Eric Y Hayden; David B Teplow
Journal:  Alzheimers Res Ther       Date:  2013-11-29       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.